Nature Communications (Jan 2024)
The chromatin landscape of healthy and injured cell types in the human kidney
- Debora L. Gisch,
- Michelle Brennan,
- Blue B. Lake,
- Jeannine Basta,
- Mark S. Keller,
- Ricardo Melo Ferreira,
- Shreeram Akilesh,
- Reetika Ghag,
- Charles Lu,
- Ying-Hua Cheng,
- Kimberly S. Collins,
- Samir V. Parikh,
- Brad H. Rovin,
- Lynn Robbins,
- Lisa Stout,
- Kimberly Y. Conklin,
- Dinh Diep,
- Bo Zhang,
- Amanda Knoten,
- Daria Barwinska,
- Mahla Asghari,
- Angela R. Sabo,
- Michael J. Ferkowicz,
- Timothy A. Sutton,
- Katherine J. Kelly,
- Ian H. De Boer,
- Sylvia E. Rosas,
- Krzysztof Kiryluk,
- Jeffrey B. Hodgin,
- Fadhl Alakwaa,
- Seth Winfree,
- Nichole Jefferson,
- Aydın Türkmen,
- Joseph P. Gaut,
- Nils Gehlenborg,
- Carrie L. Phillips,
- Tarek M. El-Achkar,
- Pierre C. Dagher,
- Takashi Hato,
- Kun Zhang,
- Jonathan Himmelfarb,
- Matthias Kretzler,
- Shamim Mollah,
- the Kidney Precision Medicine Project (KPMP),
- Sanjay Jain,
- Michael Rauchman,
- Michael T. Eadon
Affiliations
- Debora L. Gisch
- Indiana University School of Medicine
- Michelle Brennan
- Saint Louis University
- Blue B. Lake
- Department of Bioengineering, University of California, San Diego
- Jeannine Basta
- Washington University in Saint Louis
- Mark S. Keller
- Harvard Medical School
- Ricardo Melo Ferreira
- Indiana University School of Medicine
- Shreeram Akilesh
- University of Washington –
- Reetika Ghag
- Washington University in Saint Louis
- Charles Lu
- Washington University in Saint Louis
- Ying-Hua Cheng
- Indiana University School of Medicine
- Kimberly S. Collins
- Indiana University School of Medicine
- Samir V. Parikh
- Ohio State University Wexner Medical Center
- Brad H. Rovin
- Ohio State University Wexner Medical Center
- Lynn Robbins
- St. Louis Veteran Affairs Medical Center
- Lisa Stout
- Washington University in Saint Louis
- Kimberly Y. Conklin
- Department of Bioengineering, University of California, San Diego
- Dinh Diep
- Department of Bioengineering, University of California, San Diego
- Bo Zhang
- Washington University in Saint Louis
- Amanda Knoten
- Washington University in Saint Louis
- Daria Barwinska
- Indiana University School of Medicine
- Mahla Asghari
- Indiana University School of Medicine
- Angela R. Sabo
- Indiana University School of Medicine
- Michael J. Ferkowicz
- Indiana University School of Medicine
- Timothy A. Sutton
- Indiana University School of Medicine
- Katherine J. Kelly
- Indiana University School of Medicine
- Ian H. De Boer
- University of Washington –
- Sylvia E. Rosas
- Joslin Diabetes Center, Harvard Medical School
- Krzysztof Kiryluk
- Columbia University
- Jeffrey B. Hodgin
- University of Michigan
- Fadhl Alakwaa
- University of Michigan
- Seth Winfree
- University of Nebraska Medical Center
- Nichole Jefferson
- Kidney Precision Medicine Project Community Engagement Committee
- Aydın Türkmen
- Istanbul School of Medicine, Division of Nephrology
- Joseph P. Gaut
- Department of Bioengineering, University of California, San Diego
- Nils Gehlenborg
- Harvard Medical School
- Carrie L. Phillips
- Indiana University School of Medicine
- Tarek M. El-Achkar
- Indiana University School of Medicine
- Pierre C. Dagher
- Indiana University School of Medicine
- Takashi Hato
- Indiana University School of Medicine
- Kun Zhang
- Department of Bioengineering, University of California, San Diego
- Jonathan Himmelfarb
- University of Washington –
- Matthias Kretzler
- University of Michigan
- Shamim Mollah
- Washington University in Saint Louis
- the Kidney Precision Medicine Project (KPMP)
- Sanjay Jain
- Washington University in Saint Louis
- Michael Rauchman
- Washington University in Saint Louis
- Michael T. Eadon
- Indiana University School of Medicine
- DOI
- https://doi.org/10.1038/s41467-023-44467-6
- Journal volume & issue
-
Vol. 15,
no. 1
pp. 1 – 21
Abstract
Abstract There is a need to define regions of gene activation or repression that control human kidney cells in states of health, injury, and repair to understand the molecular pathogenesis of kidney disease and design therapeutic strategies. Comprehensive integration of gene expression with epigenetic features that define regulatory elements remains a significant challenge. We measure dual single nucleus RNA expression and chromatin accessibility, DNA methylation, and H3K27ac, H3K4me1, H3K4me3, and H3K27me3 histone modifications to decipher the chromatin landscape and gene regulation of the kidney in reference and adaptive injury states. We establish a spatially-anchored epigenomic atlas to define the kidney’s active, silent, and regulatory accessible chromatin regions across the genome. Using this atlas, we note distinct control of adaptive injury in different epithelial cell types. A proximal tubule cell transcription factor network of ELF3, KLF6, and KLF10 regulates the transition between health and injury, while in thick ascending limb cells this transition is regulated by NR2F1. Further, combined perturbation of ELF3, KLF6, and KLF10 distinguishes two adaptive proximal tubular cell subtypes, one of which manifested a repair trajectory after knockout. This atlas will serve as a foundation to facilitate targeted cell-specific therapeutics by reprogramming gene regulatory networks.